Selected Talks

ANNA 35th National Symposium
April, 2004
Access to this symposium is free, but to take the post-test you must first be a registered FREE ZONE user of HDCN. The CE credits provided by ANNA require a fee, as detailed at this link. If not already an HDCN FREE ZONE user, please register at this link and select a username and password.
Celebrating 50 Years of Transplantation: Past, Present, and Future
Patricia Weiskittel RN,MSN,CNN,CS,ARNP,BC
Chronic Kidney Disease& DYSLIPIDEMIA. Part 1 or 2.
Sally Campoy, RN, MS, CS, CNN, ANP
Chronic Kidney Disease& DYSLIPIDEMIA. Part 2 or 2.
Sally Campoy, RN, MS, CS, CNN, ANP
Alport’s Syndrome Strep D (AKA enterococcus).
Mary Schira, PhD, RN, APRN, BC, ACNP
Bones, Moans, and Groans: Skeletal Disorders in Chronic Kidney Disease. Part 1 of 2.
Kim Alleman, MS, RN, FNP, CNN
Bones, Moans, and Groans: Skeletal Disorders in Chronic Kidney Disease. Part 2 of 2.
Kim Alleman, MS, RN, FNP, CNN


Activity goal: Please see individual talks.
Kim Alleman, MS, RN, FNP, CNN

Sally Campoy, RN, MS, CS, CNN, ANP

Mary Schira, PhD, RN, APRN, BC, ACNP

Patricia Weiskittel RN, MSN, CNN, CS, ARNP, BC

Each talk, depending on its length, is acredited by the American Nephrology Nurses' Association (ANNA)
Date of Original Release: See individual talks
CE Credit Eligible Through: See individual talks
Contact Hours/Completion Time: See individual talks Target Audiences: Nephrology nurses and technicians.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the posttest, read the linked abstracts in the posttest, answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several hundred thousand require renal replacement therapy. These selected lectures will allow nephrology nurses, pharmacists, and technicians to obtain up-to-date information about issues related to care of renal patients.

ACCREDITATION STATEMENT:
This offering for 1.5 contact hours is being provided by the American Nephrology Nurses Association (ANNA), which is accredited as a provider and approver of continuing education in nursing by the American Nurses Credentialing Center-Commission on Accreditation (ANCCCOA). This educational activity is approved by most states and specialty organizations that recognize the ANCC-COA accreditation process. ANNA is an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN Provider No. 00910; and the Kansas State Board of Nursing, Provider No. LT0148-0738. This offering is accepted for RN and LPN relicensure in Kansas.

FACULTY DISCLOSURE STATEMENTS :
The American Nephrology Nurses' Association, as well as HDCN have conflict of interest policies that require course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Kim Alleman discloses no conflict of interest. Sally Campoy discloses no conflict of interest. Mary Schira discloses no conflict of interest. Patricia Weiskittel discloses no conflict of interest.
DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Nephrology Nurses' Association, and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.